urmc.rochester.edu
Sep 17, 2026, 14:23
Neil Blumberg: ABO Nonidentical Transfusions and Mortality in Massive Transfusion
Neil Blumberg, Professor, Director of Transfusion Medicine/Blood Bank at University of Rochester Medical Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, published in Jama Surgery, adding:
“ABO mismatched transfusions likely harm patients experiencing severe hemorrhage undergoing massive transfusion protocol”
Title: ABO Nonidentical Transfusions and Mortality in Patients Undergoing Massive Transfusion Protocol
Authores: Neil Blumberg, Kelly Henrichs, Debra Masel, Michael Vella, Mark Gestring, Amanda Lippa, Phuong-Lan Nguyen, Akua Asante, Christine Cahill, Majed Refaai
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE
-
Nov 2, 2026, 12:31Toby Richards: Screening for Iron Deficiency – Nearly 1 in 4 Women Anaemic